148 related articles for article (PubMed ID: 21161752)
1. Neural substrates of psychostimulant withdrawal-induced anhedonia.
D'Souza MS; Markou A
Curr Top Behav Neurosci; 2010; 3():119-78. PubMed ID: 21161752
[TBL] [Abstract][Full Text] [Related]
2. Repeated electroconvulsive shock attenuates the depressive-like effects of d-amphetamine withdrawal on brain reward function in rats.
Barr AM; Zis AP; Phillips AG
Psychopharmacology (Berl); 2002 Jan; 159(2):196-202. PubMed ID: 11862349
[TBL] [Abstract][Full Text] [Related]
3. Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine.
Zhornitsky S; Potvin S; Stip E; Rompré PP
Eur Neuropsychopharmacol; 2010 Oct; 20(10):695-703. PubMed ID: 20605419
[TBL] [Abstract][Full Text] [Related]
4. Animal models and treatments for addiction and depression co-morbidity.
Paterson NE; Markou A
Neurotox Res; 2007 Jan; 11(1):1-32. PubMed ID: 17449445
[TBL] [Abstract][Full Text] [Related]
5. Psychostimulant withdrawal as an inducing condition in animal models of depression.
Barr AM; Markou A
Neurosci Biobehav Rev; 2005; 29(4-5):675-706. PubMed ID: 15893821
[TBL] [Abstract][Full Text] [Related]
6. Anhedonia, self-experience in schizophrenia, and implications for treatment.
Juckel G; Sass L; Heinz A
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S176-80. PubMed ID: 14677076
[TBL] [Abstract][Full Text] [Related]
7. The role of corticotropin-releasing factor in drug addiction.
Sarnyai Z; Shaham Y; Heinrichs SC
Pharmacol Rev; 2001 Jun; 53(2):209-43. PubMed ID: 11356984
[TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.
Cunha-Oliveira T; Rego AC; Oliveira CR
Brain Res Rev; 2008 Jun; 58(1):192-208. PubMed ID: 18440072
[TBL] [Abstract][Full Text] [Related]
9. Effect of an mGlu2/3 receptor antagonist on depressive behavior induced by withdrawal from chronic treatment with methamphetamine.
Iijima M; Koike H; Chaki S
Behav Brain Res; 2013 Jun; 246():24-8. PubMed ID: 23473878
[TBL] [Abstract][Full Text] [Related]
10. A 'crash' course on psychostimulant withdrawal as a model of depression.
Barr AM; Markou A; Phillips AG
Trends Pharmacol Sci; 2002 Oct; 23(10):475-82. PubMed ID: 12368072
[TBL] [Abstract][Full Text] [Related]
11. Addictiveness of central stimulants.
Dackis CA; Gold MS
Adv Alcohol Subst Abuse; 1990; 9(1-2):9-26. PubMed ID: 1974121
[TBL] [Abstract][Full Text] [Related]
12. Neurobiologic basis of nicotine addiction and psychostimulant abuse: a role for neurotensin?
Fredrickson P; Boules M; Lin SC; Richelson E
Psychiatr Clin North Am; 2005 Sep; 28(3):737-51, 746. PubMed ID: 16122577
[TBL] [Abstract][Full Text] [Related]
13. Anhedonia and substance-related symptoms in detoxified substance-dependent subjects: a correlation study.
Janiri L; Martinotti G; Dario T; Reina D; Paparello F; Pozzi G; Addolorato G; Di Giannantonio M; De Risio S
Neuropsychobiology; 2005; 52(1):37-44. PubMed ID: 15942262
[TBL] [Abstract][Full Text] [Related]
14. The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables.
Pozzi G; Martinotti G; Reina D; Dario T; Frustaci A; Janiri L; Bria P
Subst Use Misuse; 2008; 43(5):722-32. PubMed ID: 18393086
[TBL] [Abstract][Full Text] [Related]
15. Functional neural substrates of self-reported physical anhedonia in non-clinical individuals and in patients with schizophrenia.
Harvey PO; Armony J; Malla A; Lepage M
J Psychiatr Res; 2010 Aug; 44(11):707-16. PubMed ID: 20116072
[TBL] [Abstract][Full Text] [Related]
16. Addiction and the brain: the neurobiology of compulsion and its persistence.
Hyman SE; Malenka RC
Nat Rev Neurosci; 2001 Oct; 2(10):695-703. PubMed ID: 11584307
[TBL] [Abstract][Full Text] [Related]
17. Microarray studies of psychostimulant-induced changes in gene expression.
Yuferov V; Nielsen D; Butelman E; Kreek MJ
Addict Biol; 2005 Mar; 10(1):101-18. PubMed ID: 15849024
[TBL] [Abstract][Full Text] [Related]
18. Psychostimulant drugs and a dopamine hypothesis regarding addiction: update on recent research.
Ritz MC; Kuhar MJ
Biochem Soc Symp; 1993; 59():51-64. PubMed ID: 7910741
[TBL] [Abstract][Full Text] [Related]
19. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
[TBL] [Abstract][Full Text] [Related]
20. Genes and molecules that can potentiate or attenuate psychostimulant dependence: relevance of data from animal models to human addiction.
Niwa M; Yan Y; Nabeshima T
Ann N Y Acad Sci; 2008 Oct; 1141():76-95. PubMed ID: 18991952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
